BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pragti, Kundu BK, Mukhopadhyay S. Target based chemotherapeutic advancement of ruthenium complexes. Coordination Chemistry Reviews 2021;448:214169. [DOI: 10.1016/j.ccr.2021.214169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Starosta R, Santos TC, Dinis de Sousa AF, Santos MS, Corvo ML, Tomaz AI, de Almeida RFM. Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds. Front Mol Biosci 2022;9:1059116. [PMID: 36660430 DOI: 10.3389/fmolb.2022.1059116] [Reference Citation Analysis]
2 Sharma VK, Assaraf YG, Gross Z. Hallmarks of anticancer and antimicrobial activities of corroles. Drug Resistance Updates 2023. [DOI: 10.1016/j.drup.2023.100931] [Reference Citation Analysis]
3 Kumar Kundu B. Introduction to sensors and types of biosensors. Multifaceted Bio-Sensing Technology 2023. [DOI: 10.1016/b978-0-323-90807-8.00002-6] [Reference Citation Analysis]
4 Naithani S, Goswami T, Thetiot F, Kumar S. Imidazo[4,5-f][1,10]phenanthroline based luminescent probes for anion recognition: Recent achievements and challenges. Coordination Chemistry Reviews 2023;475:214894. [DOI: 10.1016/j.ccr.2022.214894] [Reference Citation Analysis]
5 Ma XY, Zhao JF, Ruan Y, Zhang WM, Zhang LQ, Cai ZD, Xu HQ. ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin. Molecules 2022;27. [PMID: 36557923 DOI: 10.3390/molecules27248790] [Reference Citation Analysis]
6 Thakur MS, Singh N, Sharma A, Rana R, Abdul Syukor A, Naushad M, Kumar S, Kumar M, Singh L. Metal coordinated macrocyclic complexes in different chemical transformations. Coordination Chemistry Reviews 2022;471:214739. [DOI: 10.1016/j.ccr.2022.214739] [Reference Citation Analysis]
7 Liang L, Wu X, Shi C, Wen H, Wu S, Chen J, Huang C, Wang Y, Liu Y. Synthesis and characterization of polypyridine ruthenium(II) complexes and anticancer efficacy studies in vivo and in vitro. J Inorg Biochem 2022;236:111963. [PMID: 35988387 DOI: 10.1016/j.jinorgbio.2022.111963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lai Y, Lu N, Luo S, Wang H, Zhang P. A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption. J Med Chem 2022. [PMID: 36134739 DOI: 10.1021/acs.jmedchem.2c00880] [Reference Citation Analysis]
9 Yang Q, Ma R, Gu Y, Xu X, Chen Z, Liang H. Arene‐Ruthenium(II)/Osmium(II) Complexes Potentiate the Anticancer Efficacy of Metformin via Glucose Metabolism Reprogramming. Angew Chem Int Ed 2022;61. [DOI: 10.1002/anie.202208570] [Reference Citation Analysis]
10 Dimbarre Lao Guimarães I, Marszaukowski F, Buhrer Rutka P, Felipe Borge L, Augusto Pontes Ribeiro R, Ricardo de Lazaro S, Castellen P, Sagoe-wagner A, Golsteyn RM, Boeré RT, Wohnrath K. Synthesis, characterization and anticancer activities of cationic η6-p-cymene ruthenium(II) complexes containing phosphine and nitrogenous ligands. Polyhedron 2022;224:115980. [DOI: 10.1016/j.poly.2022.115980] [Reference Citation Analysis]
11 Kanaoujiya R, Meenakshi, Srivastava S, Singh R, Mustafa G. Recent advances and application of ruthenium complexes in tumor malignancy. Materials Today: Proceedings 2022. [DOI: 10.1016/j.matpr.2022.07.098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ciesielska A, Gawrońska M, Makowski M, Ramotowska S. Sulfonamides differing in the alkylamino substituent length – Synthesis, electrochemical characteristic, acid-base profile and complexation properties. Polyhedron 2022;221:115868. [DOI: 10.1016/j.poly.2022.115868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Manzano CM, Nakahata DH, de Paiva RE. Revisiting metallodrugs for the treatment of skin cancers. Coordination Chemistry Reviews 2022;462:214506. [DOI: 10.1016/j.ccr.2022.214506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pragti, Kundu BK, Upadhyay SN, Sinha N, Ganguly R, Grabchev I, Pakhira S, Mukhopadhyay S. Pyrene-based fluorescent Ru(II)-arene complexes for significant biological applications: catalytic potential, DNA/protein binding, two photon cell imaging and in vitro cytotoxicity. Dalton Trans 2022;51:3937-53. [PMID: 35171173 DOI: 10.1039/d1dt04093f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Luiz Moreira do Amaral M, Nascimento RD, Franco Silva L, Christine de Souza Arantes E, Graminha AE, Santana da Silva R, Ueno LT, Luiz Bogado A, Defreitas-silva G, Galvão de Lima R. New trans-[Ru(NO)(NO2)(dppb)(o-bdqi)]+ complex as NO donor encapsulated Pluronic F-127 micelles. Polyhedron 2022. [DOI: 10.1016/j.poly.2022.115770] [Reference Citation Analysis]
16 Zhang L, Li HM, Chen JL, She WY, Zhao Y, Liu Y, Jiang FL, Liu Y, Jiang P. Multifunctional Probes with High Utilization Rates: Self-Assembled Merocyanine Nanoparticles in Water as Acid-Base Indicators and Mitochondrion-Targeting Chemotherapeutic Agents. J Phys Chem Lett 2022;:1090-8. [PMID: 35080405 DOI: 10.1021/acs.jpclett.1c04092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kundu BK, Pragti, Carlton Ranjith WA, Shankar U, Kannan RR, Mobin SM, Bandyopadhyay A, Mukhopadhyay S. Cancer-Targeted Chitosan-Biotin-Conjugated Mesoporous Silica Nanoparticles as Carriers of Zinc Complexes to Achieve Enhanced Chemotherapy In Vitro and In Vivo. ACS Appl Bio Mater 2022;5:190-204. [PMID: 35014809 DOI: 10.1021/acsabm.1c01041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]